| Net Cash Provided by (Used in) Operating Activities |
$354,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$111,000 |
USD |
1486% |
Q1 2024 |
Q1 2024 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Common Stock, Shares, Issued |
15,053,048 |
shares |
0.32% |
Q2 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$2,501,000 |
USD |
74% |
Q2 2025 |
Q2 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$5,000 |
USD |
-38% |
Q1 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$100,210,000 |
USD |
-9.9% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$100,955,000 |
USD |
-10% |
Q4 2024 |
FY 2024 |
| Property, Plant and Equipment, Gross |
$508,000 |
USD |
-94% |
Q2 2025 |
Q2 2025 |
| Operating Lease, Liability, Current |
$18,000 |
USD |
-83% |
Q4 2024 |
Q2 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$94,767,000 |
USD |
-9.7% |
Q4 2024 |
FY 2024 |
| Current Income Tax Expense (Benefit) |
$0 |
USD |
|
Q2 2025 |
Q2 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q2 2025 |
Q2 2025 |
| Depreciation, Depletion and Amortization |
$495,000 |
USD |
138% |
Q3 2024 |
Q3 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q2 2025 |
Q2 2025 |
| Share-based Payment Arrangement, Expense |
$320,000 |
USD |
-26% |
Q2 2025 |
Q2 2025 |